Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndromeLanlan Zhou, Xueyi Pan, Zhenzhen Wen et al.|Journal of Cancer Research and Clinical Oncology|2020Cited by 47